Emmett V Schmidt

3PUBLICATIONS
17CO-AUTHORS
Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jan 06, 2023
A Phase Ib/II Study of Lenvatinib and Pembrolizumab in Advanced Endometrial Carcinoma (Study 111/KEYNOTE-146): Long-Term Efficacy and Safety Update.

Vicky Makker, Carol Aghajanian, Allen L Cohn

|Aug 29, 2020
MHC class II transactivator CIITA induces cell resistance to Ebola virus and SARS-like coronaviruses.

Anna Bruchez, Ky Sha, Joshua Johnson

|Oct 31, 2018
Developing combination strategies using PD-1 checkpoint inhibitors to treat cancer.

Emmett V Schmidt

Pageof 1